Cargando…

Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trial

BACKGROUND: Previous trials of the RTS, S malaria candidate vaccine have shown that this vaccine is safe, tolerated and immunogenic. The development plan for this vaccine aims at administering it in the first year of life through the Expanded Program on Immunization (EPI). The objective was to evalu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Macete, Eusebio V, Sacarlal, Jahit, Aponte, John J, Leach, Amanda, Navia, Margarita M, Milman, Jessica, Guinovart, Caterina, Mandomando, Inacio, López-Púa, Yolanda, Lievens, Marc, Owusu-Ofori, Alex, Dubois, Marie-Claude, Cahill, Conor P, Koutsoukos, Marguerite, Sillman, Marla, Thompson, Ricardo, Dubovsky, Filip, Ballou, W Ripley, Cohen, Joe, Alonso, Pedro L
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1847838/ https://www.ncbi.nlm.nih.gov/pubmed/17386091 http://dx.doi.org/10.1186/1745-6215-8-11

Ejemplares similares

Insights into Long-Lasting Protection Induced by RTS,S/AS02A Malaria Vaccine: Further Results from a Phase IIb Trial in Mozambican Children
por: Guinovart, Caterina, et al.
Publicado: (2009)

Safety, Immunogenicity and Duration of Protection of the RTS,S/AS02(D) Malaria Vaccine: One Year Follow-Up of a Randomized Controlled Phase I/IIb Trial
por: Aide, Pedro, et al.
Publicado: (2010)

Impact of the RTS,S Malaria Vaccine Candidate on Naturally Acquired Antibody Responses to Multiple Asexual Blood Stage Antigens
por: Campo, Joseph J., et al.
Publicado: (2011)

RTS,S/AS02A Malaria Vaccine Does Not Induce Parasite CSP T Cell Epitope Selection and Reduces Multiplicity of Infection
por: Enosse, Sonia, et al.
Publicado: (2006)

Malaria in rural Mozambique. Part II: children admitted to hospital
por: Bassat, Quique, et al.
Publicado: (2008)

Malaria in rural Mozambique. Part I: Children attending the outpatient clinic
por: Guinovart, Caterina, et al.
Publicado: (2008)

Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa
por: Leach, Amanda, et al.
Publicado: (2011)

Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
por: Polhemus, Mark E., et al.
Publicado: (2009)

Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure
por: Kurtovic, Liriye, et al.
Publicado: (2019)

A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01(E) and RTS,S/AS01(B) Delayed Fractional Dose Regimens in Malaria-Naive Adults
por: Moon, James E, et al.
Publicado: (2020)

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on Genotypes of P. falciparum in Adults Participating in a Malaria Vaccine Clinical Trial
por: Waitumbi, John N., et al.
Publicado: (2009)

Varying efficacy of intermittent preventive treatment for malaria in infants in two similar trials: public health implications
por: Menendez, Clara, et al.
Publicado: (2007)

Induction, decay, and determinants of functional antibodies following vaccination with the RTS,S malaria vaccine in young children
por: Feng, Gaoqian, et al.
Publicado: (2022)

A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine
por: White, Michael T, et al.
Publicado: (2014)

Randomized Controlled Trial of RTS,S/AS02(D) and RTS,S/AS01(E) Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
por: Owusu-Agyei, Seth, et al.
Publicado: (2009)

Correction: Randomized Controlled Trial of RTS,S/AS02(D) and RTS,S/AS01(E) Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
por: Owusu-Agyei, Seth, et al.
Publicado: (2010)

Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02(D) malaria vaccine in infants living in a malaria-endemic region
por: Abdulla, Salim, et al.
Publicado: (2013)

A Randomized Trial Assessing the Safety and Immunogenicity of AS01 and AS02 Adjuvanted RTS,S Malaria Vaccine Candidates in Children in Gabon
por: Lell, Bertrand, et al.
Publicado: (2009)

Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial
por: van den Berg, Robert A., et al.
Publicado: (2017)

RTS,S: the first malaria vaccine
por: Zavala, Fidel
Publicado: (2022)

Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data
por: Moorthy, Vasee S, et al.
Publicado: (2009)

A prospective cohort study to assess the micro-epidemiology of Plasmodium falciparum clinical malaria in Ilha Josina Machel (Manhiça, Mozambique)
por: Galatas, Beatriz, et al.
Publicado: (2016)

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS,S/AS01 malaria vaccine in African children
por: Lievens, Marc, et al.
Publicado: (2011)

Prescription practices for malaria in Mozambique: poor adherence to the national protocols for malaria treatment in 22 public health facilities
por: Salomão, Cristolde A., et al.
Publicado: (2015)

Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi
por: Bell, Griffin J., et al.
Publicado: (2020)

Safety of the Malaria Vaccine Candidate, RTS,S/AS01(E) in 5 to 17 Month Old Kenyan and Tanzanian Children
por: Lusingu, John, et al.
Publicado: (2010)

CXCR3(+) T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and Efficacy Against Malaria
por: Bowyer, Georgina, et al.
Publicado: (2018)

RTS,S Malaria Vaccine and Increased Mortality in Girls
por: Klein, Sabra L., et al.
Publicado: (2016)

The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01
por: Fortpied, Juliette, et al.
Publicado: (2020)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01(E) in 5 to 17 Month Old Kenyan and Tanzanian Children
por: Lusingu, John, et al.
Publicado: (2010)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01(E) in 5 to 17 Month Old Kenyan and Tanzanian Children
por: Lusingu, John, et al.
Publicado: (2010)

RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype
por: Nielsen, C.M., et al.
Publicado: (2018)

Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa
por: Otieno, Lucas, et al.
Publicado: (2020)

The RTS,S malaria vaccine: Journey from conception to recommendation
por: Egbewande, Oluwaseyi Muyiwa
Publicado: (2022)

Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children
por: Ubillos, Itziar, et al.
Publicado: (2018)

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa
por: Guerra Mendoza, Yolanda, et al.
Publicado: (2019)

T Cell Responses to the RTS,S/AS01(E) and RTS,S/AS02(D) Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children
por: Ansong, Daniel, et al.
Publicado: (2011)

Policy analysis for deciding on a malaria vaccine RTS,S in Tanzania
por: Romore, Idda, et al.
Publicado: (2016)

The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan
por: Gosling, Roly, et al.
Publicado: (2016)

Clinical malaria in African pregnant women
por: Bardají, Azucena, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_vr8k52v3fv6sdnpobtaruprh1f